Benzinga | Aug 12, 2020 07:36AM EDT

Frequency Therapeutics Q2 EPS $(0.19), Sales $8.50M

Frequency Therapeutics (NASDAQ:FREQ) reported quarterly losses of $(0.19) per share. The company reported $8.50 million in sales this quarter.